A comparison of treatment with ezetimibe (SCH 58235) and simvastatin coadministration versus simvastatin in attaining the national cholesterol education program (NCEP) adult treatment panel (ATP) III coronary heart disease (CHD) or CHD risk equivalent strata low-density lipoprotein cholesterol (LDL-C) target level
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 02 Feb 2006
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 02 Feb 2006 New trial record.